Management of neuroendocrine differentiated breast carcinoma

Breast

Volumn 13, Issue 6, 2004, Pages 527-529

  Berruti, A ^a   Saini, A ^a   Leonardo, E ^a   Cappia, S ^a   Borasio, P ^a   Dogliotti, Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chemotherapy; Hormone therapy; Marker; Neuroendocrine differentiated breast carcinoma; Resection

Indexed keywords

CHROMOGRANIN A; EPIRUBICIN; LETROZOLE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MASTECTOMY; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; THORACOTOMY; TUMOR DIFFERENTIATION;

EID: 10244241945     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2004.06.007     Document Type: Article

References (5)

1. A. Miremadi S.E. Pinder A.H. Lee et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma Histopathology 40 2002 215-222
2. A. Sapino L. Righi P. Cassoni M. Papotti F. Pietribasi G. Bussolati Expression of the neuroendocrine phenotype in carcinomas of the breast Semin Diagn Pathol 17 2000 127-137
3. O. Zekioglu Y. Erhan M. Ciris H. Bayramoglu Neuroendocrine differentiated carcinomas of the breast a distinct entity Breast 12 2003 251-257
4. A. Sapino G. Bussolati Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance? Histopathology 40 2002 211-214
5. A. Sapino M. Papotti L. Righi P. Cassoni L. Chiusa G. Bussolati Clinical significance of neuroendocrine carcinoma of the breast Ann Oncol 12 Suppl. 2 2001 115-117